We have shown, in the present study that the inhibitory effect of hCDR1 on the expression of the IFN-α gene is specific to lupus and it does not affect healthy controls and patients with APS (Figure 3). This evidence concerns the gene IFNA1 and autoimmune polyendocrinopathy.